Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › Westborough › NPI 1649572017
Lab

Esoterix Genetic Laboratories, LLC

Esoterix Genetic Laboratories, LLC was paid $2.97M by Medicaid between Jan 2018 and Dec 2024, across 32 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 44% of everything it billed.

33Billing provider infoESOTERIX GENETIC LABORATORIES, LLC
WESTBOROUGH, MA 01581
33aNPI1649572017assigned 11/17/2010
28Total paid$2.97M
24GClaims62,256
24DCodes billed32
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Massachusetts

Rank by total paid#16 of 63
Median peer was paid$473K
This provider vs. median6.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20186,556$254K
20196,294$238K
202012,423$771K
202124,389$1.15M
20225,041$209K
20233,978$150K
2024incomplete3,575$197K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 44% 16,211 14,255 $1.30M
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 37% 3,668 3,648 $1.09M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 5.9% 7,270 6,156 $176K
84702 3.8% 9,363 9,136 $113K
82677 2.4% 4,179 4,173 $73K
84163 2.1% 5,062 5,052 $62K
82105 1.7% 7,631 7,597 $52K
86336 <1% 4,180 4,174 $28K
81401 <1% 432 416 $23K
88235 <1% 172 170 $20K
88185 <1% 45 44 $14K
81329 <1% 1,210 1,204 $14K
20 more codes
81243 <1% 2,255 $3K
88262 <1% 28 $3K
88189 <1% 78 $2K
88233 <1% 13 $2K
88184 <1% 45 $1K
88342 <1% 45 $989.43
88230 <1% 12 $500.98
81361 <1% 27 $419.53
82106 <1% 13 $111.10
81260 <1% 27 $94.32
81257 <1% 13 $15.78
99001 0% 181 $0.00
81290 0% 12 $0.00
81255 0% 12 $0.00
81242 0% 12 $0.00
81251 0% 12 $0.00
81330 0% 12 $0.00
96040 0% 12 $0.00
81200 0% 12 $0.00
81209 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILLIAMS, KIMBERLY (VICE PRESIDENT)
Same official

Other billing entities under WILLIAMS, KIMBERLY

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.